Others

Statement of deviation or variation for the quarter ended December 31, 2016

| Updated on February 01, 2018 Published on January 12, 2017

Mavens Biotech Ltd has submitted to BSE a copy of the statement of deviation or variation in public issue, right issue, preferential issue etc. for the quarter ended December 31, 2016.

Pdf Link: Statement of deviation or variation for the quarter ended December 31, 2016

Source : BSE - www.bseindia.com

Published on January 12, 2017
This article is closed for comments.
Please Email the Editor